These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 22580905)
1. pH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties. Hsieh YL; Ilevbare GA; Van Eerdenbrugh B; Box KJ; Sanchez-Felix MV; Taylor LS Pharm Res; 2012 Oct; 29(10):2738-53. PubMed ID: 22580905 [TBL] [Abstract][Full Text] [Related]
2. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs. Indulkar AS; Box KJ; Taylor R; Ruiz R; Taylor LS Mol Pharm; 2015 Jul; 12(7):2365-77. PubMed ID: 25984769 [TBL] [Abstract][Full Text] [Related]
3. Crystallization of a salt of a weak organic acid and base: solubility relations, supersaturation control and polymorphic behavior. Jones HP; Davey RJ; Cox BG J Phys Chem B; 2005 Mar; 109(11):5273-8. PubMed ID: 16863194 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Pazopanib Phase Behavior Following pH-Induced Supersaturation. Sugihara H; Taylor LS Mol Pharm; 2018 Apr; 15(4):1690-1699. PubMed ID: 29502424 [TBL] [Abstract][Full Text] [Related]
5. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions. Xie T; Gao W; Taylor LS Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901 [TBL] [Abstract][Full Text] [Related]
6. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles. Han YR; Lee PI Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
8. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Madsen CM; Boyd B; Rades T; Müllertz A Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089 [TBL] [Abstract][Full Text] [Related]
9. Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations. Alskär LC; Keemink J; Johannesson J; Porter CJH; Bergström CAS Mol Pharm; 2018 Oct; 15(10):4733-4744. PubMed ID: 30142268 [TBL] [Abstract][Full Text] [Related]
10. Comparison of induction methods for supersaturation: pH shift versus solvent shift. Plum J; Bavnhøj C; Palmelund H; Pérez-Alós L; Müllertz A; Rades T Int J Pharm; 2020 Jan; 573():118862. PubMed ID: 31759102 [TBL] [Abstract][Full Text] [Related]
11. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels. Schver GCRM; Lee PI Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723 [TBL] [Abstract][Full Text] [Related]
12. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation. Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350 [TBL] [Abstract][Full Text] [Related]
13. Phase Behavior and Crystallization Kinetics of a Poorly Water-Soluble Weakly Basic Drug as a Function of Supersaturation and Media Composition. Van Duong T; Ni Z; Taylor LS Mol Pharm; 2022 Apr; 19(4):1146-1159. PubMed ID: 35319221 [TBL] [Abstract][Full Text] [Related]
14. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin. Ojarinta R; Heikkinen AT; Sievänen E; Laitinen R Eur J Pharm Biopharm; 2017 Mar; 112():85-95. PubMed ID: 27888143 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of Supersaturation Suppression in Dissolution Process of Acidic Drug Salt. Oki J; Watanabe D; Uekusa T; Sugano K Mol Pharm; 2019 Apr; 16(4):1669-1677. PubMed ID: 30794420 [TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption. Tanaka Y; Kawakami A; Nanimatsu A; Horio M; Matsuoka J; Wada T; Kasaoka S; Yoshikawa H Eur J Pharm Sci; 2017 Jan; 96():464-471. PubMed ID: 27773836 [TBL] [Abstract][Full Text] [Related]
17. Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations. Stillhart C; Dürr D; Kuentz M J Pharm Sci; 2014 Apr; 103(4):1194-203. PubMed ID: 24515977 [TBL] [Abstract][Full Text] [Related]
18. Population Balance Model for Simulation of the Supersaturation-Precipitation Behavior of Drugs in Supersaturable Solid Forms. Ozaki S J Pharm Sci; 2019 Jan; 108(1):260-267. PubMed ID: 30092242 [TBL] [Abstract][Full Text] [Related]
19. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Psachoulias D; Vertzoni M; Goumas K; Kalioras V; Beato S; Butler J; Reppas C Pharm Res; 2011 Dec; 28(12):3145-58. PubMed ID: 21674262 [TBL] [Abstract][Full Text] [Related]